BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferrero C, Badellino S, Filippi AR, Focaraccio L, Giaj Levra M, Levis M, Moretto F, Torchio R, Ricardi U, Novello S. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study. Lung Cancer 2015;89:350-6. [PMID: 26164208 DOI: 10.1016/j.lungcan.2015.06.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Berg J, Halvorsen AR, Bengtson M, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T. Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer. Front Immunol 2022;13:875152. [DOI: 10.3389/fimmu.2022.875152] [Reference Citation Analysis]
2 Park HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ Jr, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation. J Thorac Dis 2022;14:2412-36. [PMID: 35813762 DOI: 10.21037/jtd-21-1826] [Reference Citation Analysis]
3 Noh JM, Yoo H, Lee W, Park HY, Shin SH, Pyo H. Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis. Cancers 2022;14:1445. [DOI: 10.3390/cancers14061445] [Reference Citation Analysis]
4 Payne RG, Anker CJ, Sprague BL, No HJ, Lin SH, Lester-coll NH. Active Surveillance for Early Stage Lung Cancer. Clinical Lung Cancer 2022. [DOI: 10.1016/j.cllc.2022.01.001] [Reference Citation Analysis]
5 Berg J, Ramberg C, Haugstvedt JOS, Bengtson MB, Gabrielsen AM, Brustugun OT, Halvorsen AR, Helland Å. Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers. Front Oncol 2021;11:674731. [PMID: 34109123 DOI: 10.3389/fonc.2021.674731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pompili C, Koller M, Velikova G. Choosing the right survey: the lung cancer surgery. J Thorac Dis 2020;12:6892-901. [PMID: 33282392 DOI: 10.21037/jtd.2019.12.131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
7 Nestle U, Adebahr S, Kaier K, Gkika E, Schimek-Jasch T, Hechtner M, Momm F, Gaertner J, Becker G, Grosu AL. Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial. Radiother Oncol 2020;148:82-8. [PMID: 32339780 DOI: 10.1016/j.radonc.2020.03.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zhou Y, Yan T, Zhou X, Cao P, Luo C, Zhou L, Xu Y, Liu Y, Xue J, Wang J, Wang Y, Lu Y, Liang B, Gong Y. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters. Strahlenther Onkol 2020;196:505-14. [PMID: 31828393 DOI: 10.1007/s00066-019-01552-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
9 Fountain MD, McLellan LA, Smith NL, Loughery BF, Rakowski JT, Tse HY, Hillman GG. Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury. Int J Radiat Biol 2020;96:245-56. [PMID: 31633433 DOI: 10.1080/09553002.2020.1683642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alberts L, Wolff HB, Kastelijn EA, Lagerwaard FJ, Hofman FN, Sharouni SYE, Schramel FMNH, Coupe VMH. Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery. Clin Lung Cancer 2019;20:370-377.e3. [PMID: 31182416 DOI: 10.1016/j.cllc.2019.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
11 Adebahr S, Hechtner M, Schräder N, Schimek-Jasch T, Kaier K, Duncker-Rohr V, Gkika E, Momm F, Gaertner J, Becker G, Grosu AL, Nestle U. Early Impact of Pulmonary Fractionated Stereotactic Body Radiotherapy on Quality of Life:Benefit for Patients With Low Initial Scores (STRIPE Trial). J Thorac Oncol 2019;14:408-19. [PMID: 30521969 DOI: 10.1016/j.jtho.2018.10.170] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
12 Pompili C, Absolom K, Franks K, Velikova G. Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients? J Thorac Dis 2018;10:7055-63. [PMID: 30746252 DOI: 10.21037/jtd.2018.11.89] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 2018;45:210-9. [PMID: 30286944 DOI: 10.1053/j.seminoncol.2018.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
14 Torre-Bouscoulet L, Muñoz-Montaño WR, Martínez-Briseño D, Lozano-Ruiz FJ, Fernández-Plata R, Beck-Magaña JA, García-Sancho C, Guzmán-Barragán A, Vergara E, Blake-Cerda M, Gochicoa-Rangel L, Maldonado F, Arroyo-Hernández M, Arrieta O. Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer. Respir Res 2018;19:72. [PMID: 29690880 DOI: 10.1186/s12931-018-0775-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
15 Charloux A, Quoix E. Lung segmentectomy: does it offer a real functional benefit over lobectomy? Eur Respir Rev 2017;26:170079. [DOI: 10.1183/16000617.0079-2017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
16 Niezink AGH, de Jong RA, Muijs CT, Langendijk JA, Widder J. Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters. Oncologist 2017;22:1257-64. [PMID: 28550029 DOI: 10.1634/theoncologist.2016-0324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
17 Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW Jr. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiother Oncol 2017;123:270-5. [PMID: 28460826 DOI: 10.1016/j.radonc.2017.03.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Ricardi U, Badellino S, Filippi AR. What do radiation oncologists require for future advancements in lung SBRT? Phys Med 2017;44:150-6. [PMID: 27914779 DOI: 10.1016/j.ejmp.2016.11.114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
19 Chen H, Louie AV, Boldt RG, Rodrigues GB, Palma DA, Senan S. Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review. Clinical Lung Cancer 2016;17:e141-9. [DOI: 10.1016/j.cllc.2015.12.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
20 Lischalk JW, Woo SM, Kataria S, Aghdam N, Paydar I, Repka MC, Anderson ED, Collins BT. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol 2016;5:379-87. [PMID: 28018523 DOI: 10.1007/s13566-016-0273-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
21 Takenaka R, Shibamoto Y, Miyakawa A, Hashizume C, Baba F. The Fate of Residual Tumor Masses That Persist After Stereotactic Body Radiotherapy for Solitary Lung Nodules: Will They Recur? Clin Lung Cancer 2016;17:406-11. [PMID: 26781347 DOI: 10.1016/j.cllc.2015.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
22 Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: History and updated role. Lung Cancer 2015;90:388-96. [DOI: 10.1016/j.lungcan.2015.10.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]